Correspondence 0001493152-23-026309 from Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Date: Aug. 1, 2023 · CIK: 0000793171 · Accession: 0001493152-23-026309
AI Filing Summary & Sentiment
File numbers found in text: 333-267366
Letter
3200 Cherry Creek Drive South, Suite 720
Denver, Colorado 80209
August 1, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn
Re: Vitro Biopharma, Inc.
Registration Statement on Form S-1
Filed on July 17, 2023
File No. 333-267366
WITHDRAWAL OF REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentleman:
Please refer to the acceleration request (the “Acceleration Request”) submitted on July 31, 2023 by Vitro Biopharma, Inc., in which we requested acceleration of the effective date of the above-referenced Registration Statement on Form S-1 to August 2, 2023, at 5:00 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at such time and we hereby formally withdraw the Acceleration Request.
If you have any questions regarding this request, please contact Scott Berdan of Polsinelli PC, our outside counsel, at (303) 583-8235.
Thank you for your assistance with this matter.
Sincerely,
VITRO BIOPHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
3200 Cherry Creek Drive South, Suite 720
Denver, Colorado 80209
August 1, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn
Re:
Vitro Biopharma, Inc.
Registration Statement on Form S-1
Filed on July 17, 2023
File No. 333-267366
WITHDRAWAL OF REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentleman:
Please refer to the acceleration request (the “Acceleration
Request”) submitted on July 31, 2023 by Vitro Biopharma, Inc., in which we requested acceleration of the effective date of the
above-referenced Registration Statement on Form S-1 to August 2, 2023, at 5:00 p.m. Eastern Time, in accordance with Rule 461 under the
Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at such time and
we hereby formally withdraw the Acceleration Request.
If you have any questions regarding this request, please
contact Scott Berdan of Polsinelli PC, our outside counsel, at (303) 583-8235.
Thank you for your assistance with this matter.
Sincerely,
VITRO BIOPHARMA, INC.
/s/ Nathan Haas
Name: Nathan Haas
Title: Chief Financial Officer
cc:
Scott Berdan, Esq., Polsinelli PC
Tyler Weigel, Esq., Polsinelli PC
Shashi Khiani, Esq., Polsinelli PC